Navigation Links
Women & Infants earns $3 million grant from National Institutes of Health
Date:11/18/2013

Advances in technology and medical care have dramatically improved survival for infants born prior to 30 weeks gestation and weighing less than three pounds. However, up to 50 percent of these infants may develop physical, cognitive, language and/or behavioral impairments that require extensive health care, educational and psychosocial community resources through adulthood. At this time, there is no reliable method to identify those infants who will go on to develop impairments and those who will not.

Women & Infants Hospital has earned a five-year, $3 million grant from the National Institute of Health's National Institute of Child Health and Human Development to determine the efficacy of a neurobehavioral exam that may help to identify which infants are at greatest risk for developmental impairment. Barry M. Lester, PhD, director of the Brown Center for the Study of Children at Risk at Women & Infants Hospital of Rhode Island and The Warren Alpert Medical School of Brown University, is the principal investigator. Co-principal investigator is T. Michael O'Shea, MD, of Wake Forest University.

Dr. Lester and Edward Tronick, PhD, of the University of Massachusetts, Boston, have developed a neurobehavioral exam called the NNNS, or the NICU (neonatal intensive care unit) Network Neurobehavioral Scale. This exam provides a comprehensive assessment that profiles infant neurobehavior along dimensions that researchers believe will enable them to help identify which infants are at greatest risk for developmental impairment.

"The ability to identify which infants will or will not be developmentally impaired is the 'holy grail' that would usher in a new era of preventive intervention and improve the long term outcome of these fragile babies," said Dr. Lester.

When infants are discharged from the NICU, many who have medical problems become developmentally impaired, while others do not. Likewise, some infants without medical problems become developmentally impaired, while others do not.

"The impairments that are suffered by these children are costly in many ways," explained Dr. Lester. "There is significant emotional cost to the children themselves, their parents and families, including coping with continuous fear and the possibility of crises associated with the infant's unpredictable medical course, extended hospitalizations, and uncertain neurodevelopmental and quality of life outcomes. In addition, time lost from work and other family activities combine to create an enormous burden on the family, their community, support networks, and society in general."

Over a five year period, Dr. Lester and his team will study approximately 1,000 babies born less than 30 weeks gestation at six sites across the country, including at Women & Infants Hospital. These babies will be tested with the NNNS just before discharge from the NICU and then given a series of developmental tests when they are approximately two and one-half years old.

Dr. Lester said, "We will use information about the infants' medical problems and profiles on the NNNS to predict which infants will be developmentally impaired at two and one-half years. If our predictions are accurate, we will be able to use our findings to help early intervention and follow-up programs in their care plans for the baby and to help counseling parents when the baby is discharged from the NICU. Parenting is a key factor in helping babies recover, so parenting will be a critical part of the intervention."

"The long term goal here is prevention," Dr. Lester continued. "If we can identify infants at greatest risk, then we can target interventions to reduce or eliminate later deficits, reduce the pool of infants who need services to only those at greatest risk, and effectively allocate limited resources."


'/>"/>

Contact: Amy Blustein
ablustein@wihri.org
401-681-2822
Women & Infants Hospital
Source:Eurekalert

Related biology news :

1. 2 servings of salmon a week is healthy for pregnant women and their babies
2. American Society of Plant Biologists honors early career women scientists
3. Supplement use predicts folate status in Canadian women
4. Knee injuries in women linked to motion, nervous system differences
5. Women & Infants participating in study of treatment of common viral infection in pregnancy
6. Vitamin D for pregnant women and babies -- how much is enough?
7. Breast cancer in young women: A distinct disease
8. Womens scientific achievements often overlooked and undervalued
9. Brain circuitry is different for women with anorexia and obesity
10. Considerable prevalence of both malaria, STIs exist among pregnant women in sub-Saharan Africa
11. UCSB anthropologists finds high levels of omega-3 fatty acids in breast milk of Amerindian women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... India , March 22, 2016 /PRNewswire/ ... market research report "Electronic Sensors Market for Consumer ... Proximity, & Others), Application (Communication & IT, ... Geography - Global Forecast to 2022", published ... industry is expected to reach USD 26.76 ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: